This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

25 Oct 2010

EMA Reviews Treatment Recommendations for Fabrazyme

The EMA’s Committee for Medicinal Products for Human Use has reviewed its previous recommendations on the use of Fabrazyme during the ongoing supply shortage.

Related News